Skip to main content

Table 6 Mean (M) and standard deviation (SD) of secondary outcome variables in 1011 migraine patients at baseline and after 3 months under preventive treatment (demographic data are reported in Table 1)

From: Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center

Condition MIDAS VAS ALLODYNIA PH SF36 MH SF36
Baseline M 33.30 8.82 2.81 36.59 38.67
SD 43.97 1.16 2.00 8.93 8.75
Follow-up M 21.74 8.30 2.40 38.10 39.48
SD 31.22 1.46 1.98 8.74 8.99
Within-subject ANOVA F 2.93 9.39 3.39 1.14 1.37
DF 2 2 2 2 2
P 0.053 < 0.001 0.034 0.31 0.25
  1. MANOVA, condition (baseline vs follow-up): F (Roy square) = 5.12, DF = 5, p < 0.0001; condition vs drug: F = 0.64, DF = 5, P = 0.69; condition vs migraine type: F = 1.83, DF = 5 p = 0.1; condition vs drug vs migraine type: F = 0.55, DF = 12, p = 0.88. The within-subject ANOVA results are reported
  2. PH physical Health score SF36, MH mental health score SF36